Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingke Braren

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Methods & Clinical Development|November 6, 2019
Nanobody-Enhanced Targeting of AAV Gene Therapy VectorsAnna Marei Eichhoff, Kathleen Börner, Birte Albrecht, et al.
Cardiovascular Research|October 11, 2019
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissueMarta Lemme, Ingke Braren, Maksymilian Prondzynski, et al.
Molecular Metabolism|August 2, 2024
An efficient AAV vector system of Rec2 serotype for intravenous injection to study metabolism in brown adipocytes in vivoJanina Behrens, Ingke Braren, Michelle Y Jaeckstein, et al.
The Journal of Biological Chemistry|May 2, 2019
Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular traffickingCarolin Schmidtke, Stephan Tiede, Melanie Thelen, et al.
Scientific Reports|December 5, 2019
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissueAlexander Dutsch, Paul J M Wijnker, Saskia Schlossarek, et al.
Molecular Therapy. Nucleic Acids|July 4, 2013
Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic CardiomyopathyGiulia Mearini, Doreen Stimpel, Elisabeth Krämer, et al.
EMBO Molecular Medicine|May 30, 2013
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in miceChristina Gedicke-Hornung, Verena Behrens-Gawlik, Silke Reischmann, et al.
Nature Communications|December 3, 2014
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceGiulia Mearini, Doreen Stimpel, Birgit Geertz, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart functionNiels Pietsch, Christina Yingxian Chen, Svenja Kupsch, et al.
Circulation Research|September 16, 2024
Chronic Activation of Tubulin Tyrosination Improves Heart FunctionNiels Pietsch, Christina Y Chen, Svenja Kupsch, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|November 6, 2019
Nanobody-Enhanced Targeting of AAV Gene Therapy VectorsAnna Marei Eichhoff, Kathleen Börner, Birte Albrecht, et al.
Cardiovascular Research|October 11, 2019
Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissueMarta Lemme, Ingke Braren, Maksymilian Prondzynski, et al.
Molecular Metabolism|August 2, 2024
An efficient AAV vector system of Rec2 serotype for intravenous injection to study metabolism in brown adipocytes in vivoJanina Behrens, Ingke Braren, Michelle Y Jaeckstein, et al.
The Journal of Biological Chemistry|May 2, 2019
Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular traffickingCarolin Schmidtke, Stephan Tiede, Melanie Thelen, et al.
Scientific Reports|December 5, 2019
Phosphomimetic cardiac myosin-binding protein C partially rescues a cardiomyopathy phenotype in murine engineered heart tissueAlexander Dutsch, Paul J M Wijnker, Saskia Schlossarek, et al.
Molecular Therapy. Nucleic Acids|July 4, 2013
Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic CardiomyopathyGiulia Mearini, Doreen Stimpel, Elisabeth Krämer, et al.
EMBO Molecular Medicine|May 30, 2013
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in miceChristina Gedicke-Hornung, Verena Behrens-Gawlik, Silke Reischmann, et al.
Nature Communications|December 3, 2014
Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in miceGiulia Mearini, Doreen Stimpel, Birgit Geertz, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Chronic activation of tubulin tyrosination in HCM mice and human iPSC-engineered heart tissues improves heart functionNiels Pietsch, Christina Yingxian Chen, Svenja Kupsch, et al.
Circulation Research|September 16, 2024
Chronic Activation of Tubulin Tyrosination Improves Heart FunctionNiels Pietsch, Christina Y Chen, Svenja Kupsch, et al.
Pageof 5